Skip to main content

Amlodipine and Benazepril Hydrochloride

NDC 57237-144 · Rising Pharma Holdings, Inc.

Generic nameAmlodipine and Benazepril Hydrochloride
Dosage formCAPSULE
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, BENAZEPRIL HYDROCHLORIDE
Strength5; 20 mg/1; mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Marketing categoryANDA

Packages

57237-144-01 — 100 CAPSULE in 1 BOTTLE (57237-144-01)

57237-144-05 — 500 CAPSULE in 1 BOTTLE (57237-144-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55111-586 — Amlodipine Besylate and Benazepril Hydrochloride, 55111-587 — Amlodipine Besylate and Benazepril Hydrochloride, 55154-4343 — Benazepril Hydrochloride, 55154-4344 — Benazepril Hydrochloride, 55154-6875 — Amlodipine Besylate, 55154-6892 — Amlodipine Besylate, 55154-8093 — Amlodipine Besylate, 55700-543 — Amlodipine besylate, 57237-142 — Amlodipine and Benazepril Hydrochloride, 57237-143 — Amlodipine and Benazepril Hydrochloride, 57237-145 — Amlodipine and Benazepril Hydrochloride, 57237-146 — Amlodipine and Benazepril Hydrochloride, 57237-147 — Amlodipine and Benazepril Hydrochloride, 58151-062 — amlodipine and atorvastatin, 58151-063 — amlodipine and atorvastatin, 58151-064 — amlodipine and atorvastatin, 58151-065 — amlodipine and atorvastatin, 58151-066 — amlodipine and atorvastatin, 58151-067 — amlodipine and atorvastatin, 58151-353 — amlodipine besylate, +624 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels